Effect of Repetitive TMS on Executive Function in Alcohol Use Disorder
NCT05997212, Not applicable, Recruiting, Universidad Nacional Autonoma de Mexico
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Effect of Repetitive TMS on Executive Function in Alcohol Use Disorder | ClinicalTrials.gov |
| NCT number | NCT05997212 | ClinicalTrials.gov |
| Status | Recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 44 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Universidad Nacional Autonoma de Mexico | ClinicalTrials.gov |
| Conditions | Alcohol Use Disorder | ClinicalTrials.gov |
| Interventions | Repetitive Transcranial Magnetic Stimulation, Repetitive Transcranial Magnetic Stimulation (Sham) | ClinicalTrials.gov |
| First posted | 2023-08-18 | ClinicalTrials.gov |
| Last updated | 2025-02-10 | ClinicalTrials.gov |
Registered outcomes 12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Change in Wisconsin Card Sorting Task | Baseline, 4 weeks | Measured by Wisconsin Card Sorting Task (WCST) to evaluate cognitive flexibility | ClinicalTrials.gov |
| Primary | Change STROOP effect | Baseline, 4 weeks | Measured by STROOP test to evaluate control inhibition | ClinicalTrials.gov |
| Primary | Change Visoespatial Memory | Baseline, 4 weeks | Measured by Visoespatial Memory test to evaluate visoespatial memory | ClinicalTrials.gov |
| Secondary | Change in Taskswitching Task Switch cost | Baseline, 4 weeks | Measured by Taskswitching task to evaluate cognitive flexibility | ClinicalTrials.gov |
| Secondary | Change in Flanker Task Flanker Efect | Baseline, 4 weeks | Measured by Flanker task to evaluate control inhibition | ClinicalTrials.gov |
| Secondary | Change in Nback Task accuracy | Baseline, 4 weeks | Measured by Nback task to evaluate working memory | ClinicalTrials.gov |
| Secondary | Change in Alcohol Craving (VAS) | Baseline, 4 weeks, 6 months | The craving will be measured using a 100 mm visual analogue scales | ClinicalTrials.gov |
| Secondary | Changes in psychopathological symptoms | Baseline, 4 weeks, 6 months | Measured by the Symptoms Questionnaire 90 (SCL-90) | ClinicalTrials.gov |
| Secondary | Changes in WHODAS score | Baseline, 4 weeks, 6 months | Measured by Disability Assessment Schedule (WHODAS) | ClinicalTrials.gov |
| Secondary | Changes in Anxiety | Baseline, 4 weeks, 6 months | Measured by Hamilton Anxiety Rating Scale (HARS) | ClinicalTrials.gov |
| Secondary | Changes in Depression | Baseline, 4 weeks, 6 months | Measured by Hamilton Depression Rating Scale (HDRS) | ClinicalTrials.gov |
| Secondary | Changes in functional connectivity | Baseline, 4 weeks | Functional connectivity of the dorsolateral prefrontal with the anterior cingulate cortex, measured with fMRI defined by the temporal correlation in the blood-oxygen-level-dependent signals of the regions. Higher correlations indicate stronger functional connectivity. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 4
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Card Sorting Test (Berg) | Primary outcome | ConductCognition |
| Stroop Color-Word Test | Primary outcome | ConductCognition |
| Eriksen Flanker Task | Secondary outcome | ConductCognition |
| Task Switching Test | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)